X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Torrent Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Torrent Pharma Quarterly Results   (TORR)

Here are the latest quarterly results of Torrent Pharma. For more details, see the Torrent Pharma financial fact sheet and Torrent Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Torrent Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
3
Jun-18
*
3
Sep-18
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m14,43014,34013,74014,29014,77017,22018,72018,940 
Other income Rs m5001,0401,050780740420270100 
Turnover Rs m14,93015,38014,79015,07015,51017,64018,99019,040 
Expenses Rs m11,27011,39010,77011,00011,18013,58013,95014,210 
Gross profit Rs m3,1602,9502,9703,2903,5903,6404,7704,730 
Depreciation Rs m7309708008409401,5101,5001,520 
Interest Rs m4805805605108001,2101,2201,260 
Profit before tax Rs m2,4502,4402,6602,7202,5901,3402,3202,050 
Tax Rs m1603807806802,010-940690260 
Profit after tax Rs m2,2902,0601,8802,0405802,2801,6301,790 
Gross profit margin %21.920.621.623.024.321.125.525.0 
Effective tax rate %6.515.629.325.077.6-70.129.712.7 
Net profit margin %15.914.413.714.33.913.28.79.5 
Diluted EPS Rs 13.5 12.2 11.1 12.1 3.4 13.5 9.6 10.6  
Diluted EPS (TTM) Rs 64.1 55.2 49.0 48.9 38.8 40.1 38.6 37.1  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Torrent Pharma 2QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   ALEMBIC PHARMA  WYETH LTD  PLETHICO PHARMA  BIOCON LTD  VENUS REMEDIES  

Compare TORRENT PHARMA With:   ALEMBIC PHARMA  WYETH LTD  PLETHICO PHARMA  BIOCON LTD  VENUS REMEDIES  

Compare TORRENT PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Higher; Asian Paints & Axis Bank Top Gainers(12:30 pm)

Share markets in India are presently trading on a positive note. Barring IT sector, all sectoral indices are trading in green with stocks in the realty sector and finance sector.

Views on news

TORRENT PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 12.3% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 12.3% YoY). Sales on the other hand came in at Rs 19 bn (up 32.5% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 13.3% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 13.3% YoY). Sales on the other hand came in at Rs 19 bn (up 36.2% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Patel's Exit, Election Results, and 4 'Must Have' Small Caps in These Exceptional Times(Profit Hunter)

Dec 11, 2018

RBI Governor's resignation is a statement of dissent with the way government is handling the economy's affairs and could lead to some serious market correction. Here's how to make the most of it.

Players in an Oligopoly Should Have Financials Like This(Chart Of The Day)

Dec 7, 2018

This stock has corrected 30% from peak and looks attractive at these valuations.

Should You Deploy Your Savings In Mirae Asset Equity Savings Fund?(Outside View)

Dec 7, 2018

PersonalFN briefly sheds light on the NFO: Mirae Asset Equity Savings Fund and the investment risk associated in it along with its outlook.

Should You Alter Your Mutual Fund Portfolio Based on the Election Results?(Outside View)

Dec 11, 2018

PersonalFN explains why mutual fund houses seem to be in two minds now and what should investors do in these times.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Dec 19, 2018 02:43 PM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 5-YR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS